Lifecycle board for live and exited recommendations

Accepted from analysis task analysis-2026-06-23-0830

₹4,047.00

At Rs 4,049 (flat vs entry Rs 4,047); the Rs 15,000 cr AI-factory order, ONGC offshore wins and Rs 7.79 lakh cr order book keep the Rs 4,842 target on track, with JPMorgan's Rs 5,060 target as the street-high check.

₹4,049.00

At ~Rs 3,999 (-1.2% from entry) with order momentum still strong (13 orders since July, ~Rs 1.11 lakh cr quarterly inflow est., Dubai airport win), but the core de-escalation driver has reversed: Iran struck targets including in the UAE and Hormuz is effectively shut, raising execution risk on the Gulf business that is ~a third of revenue.

₹3,999.00

At ~₹3,989 (entry ₹4,047, -1.4%), L&T has fresh support: 13 order wins since July including ~₹1.1 lakh crore of estimated Q2 inflow on Middle East revival (Bloomberg, Aug 26), Citi reiterated Buy ₹4,650 on Sep 2, and Jefferies lists it as a preferred industrial — the thesis is stronger than at entry.

₹3,989.20

Accepted from analysis task analysis-2026-06-15-0830

₹1,939.80

At Rs 1,941 (flat vs entry Rs 1,939.8); Q1 PAT +27% with Organon acquisition on track and Motilal Oswal Buy (Rs 2,310) support the Rs 2,140 target; stock sits ~8% above its 200-DMA (Rs 1,798).

₹1,941.00

₹1,881 vs entry ₹1,939.8 (-3.0%); Aug 17 fall (~-2.5%) made it a worst-in-Nifty name - now below the ~₹1,902 50-DMA though above the ₹1,798 200-DMA and the ₹1,823 stop; monitor the post-results support zone ~₹1,850.

₹1,881.00

At ₹1,898.5 vs entry ₹1,939.8 (-2.1%), the stock was on WATCH after Q1 revenue missed; it has since recovered from ~₹1,795 to ~₹1,900 (top NSE gainer on Aug 19, +1.3%) and the Organon deal remains on track, so upgrade back to HOLD with the ₹2,140 target intact.

₹1,898.50

Accepted from analysis task analysis-2026-08-14-0830

₹1,083.00

CMP ₹1,067.7 vs entry ₹1,083 (-1.4%); record Q1 (PAT +10.2% to ₹21,121 cr), ICICI Sec raised to ₹1,300, consensus Strong Buy ₹1,220; shallow pullback, well above stop (₹1,018).

₹1,067.70

At ₹1,043 vs entry ₹1,083 (-3.7%), the post-results pop to ₹1,123 has fully faded and the price has not confirmed the Q1 beat (learned rule: post-result price confirmation); the 6% stop (₹1,018) is not breached and broker targets of ₹1,290-1,350 are unchanged, so hold but do not add.

₹1,043.00

At ~₹1,060 (entry ₹1,083, -2.1%) the thesis is intact - record Q1 FY27 (PAT +10.2%, GNPA 1.47%) with ICICI Securities at ₹1,300 and consensus targets near ₹1,260 - but September is seasonally SBI's worst month (down 8 of last 10 years, avg -3.4%), so keep the existing stop (~₹1,018) and do not add.

₹1,060.00

At ~Rs 1,030 the stock is ~4.9% below entry (Rs 1,083) and within ~1% of the 6% stop (Rs 1,018) after the Sep 1 PSU-bank pullback, but the thesis is intact - Jefferies reiterated Buy (TP Rs 1,320) on Sep 1 and Q1 beat on record-low GNPA - so flag it; the automatic stop EXIT fires if Rs 1,018 breaks.

₹1,029.90

Accepted from analysis task analysis-2026-08-18-0830

₹525.20

At Rs 532 (+1.3% vs entry Rs 525.2) with Q1 PAT +260% YoY confirmed by exchange-sourced results; Axis breakout target Rs 585-599 is intact and no stop breach (Rs 493.7).

₹532.00

Post-mortem postmortem-REC-20260818-07-AARTIIND-2026-08-28 completed on 2026-08-28T03:17:00Z.

₹537.10

Accepted from analysis task analysis-2026-08-17-0830

₹2,614.50

Entered Aug 17 at ₹2,614.5, now ₹2,601.5 (-0.5%); Q1 beat (revenue +39%, PAT +44% YoY) and defence momentum intact, but price sits right at the ~₹2,628 200-DMA zone - hold with a stop discipline.

₹2,601.50

Post-mortem postmortem-REC-20260817-06-GRSE-2026-08-27 completed on 2026-08-27T03:20:29Z.

₹2,633.00

Accepted from analysis task analysis-2026-06-17-0830

₹389.40

At Rs 409.6 (+5.2% vs entry Rs 389.4) and reclaiming the 200-DMA (~Rs 410); fresh orders of Rs 541 cr and Rs 847 cr plus a Rs 72,258 cr order book keep the Rs 510 target in play (Antique Rs 532).

₹409.60

Auto-WATCH: agm event on 2026-08-28 is 4 days away

₹414.00

At ₹414 vs entry ₹389.4 (+6.3%, MFE +6.9% - the portfolio's best performer, at its peak close ₹414.1); the platform's WATCH flag is AGM-event-driven (AGM Aug 28) rather than thesis-driven, and fresh ₹541 cr orders plus a Q1 beat (PAT +8.8%, revenue +25.3%) keep the thesis working; Jefferies Buy ₹490, consensus ~₹515, review Aug 26.

₹414.00

Auto-WATCH: agm event on 2026-08-28 is 3 days away

₹408.65

₹408.65 vs entry ₹389.4 (+4.9%, best move +6.9%): fresh ₹541 cr orders (Aug 10) and ₹847 cr (early Aug) keep the book at ~₹72,258 cr; the post-Q1 margin dip has been digested and the stock recovered above entry, review due Aug 26.

₹408.65

Auto-WATCH: agm event on 2026-08-28 is 2 days away

₹411.20

Post-mortem postmortem-REC-20260805-05-BEL-2026-08-26 completed on 2026-08-26T03:21:08Z.

₹411.20

completed

upcoming

Accepted from analysis task analysis-2026-08-07-0830

₹4,651.00

Day 1 of a 10-day hold at ₹4,675.20 (+0.5% vs entry ₹4,651); fresh 52-week high on record Q1 momentum, but consensus target ₹4,665 is now at price so the remaining upside depends on momentum toward the ₹5,000 pick target.

₹4,651.00

Post-mortem postmortem-REC-20260814-07-RADICO-2026-08-24 completed on 2026-08-24T03:20:35Z.

₹4,636.00

Accepted from analysis task analysis-2026-06-11-0830

₹1,000.85

At ₹1,000.70 SBI is near entry, above its ₹991 200-DMA, and the ₹1,250 broker target keeps the value thesis intact.

₹1,001.10

Auto-WATCH: agm event on 2026-06-18 is 3 days away

₹1,016.40

At about Rs 1,052.5 SBI is 5.2% above entry, above its 200-DMA, and still below the Rs 1,150 target.

₹1,011.30

Technicals have deteriorated meaningfully: RSI slid to ~40-42 (bearish zone), daily MACD is negative across sources, and price (~₹1,039) is near 200-DMA (~₹984). Q1 FY27 results were mixed (EPS beat but revenue miss). Past review date of July 29. Strong fundamental backdrop (record FY26 profit, ₹60K Cr fundraising, consensus Strong Buy target ₹1,197) but technical weakness warrants caution.

₹1,052.30

Up 3.4% from entry at Rs 1,034.50; above 200-DMA with bullish MACD and RSI ~49-55 (neutral, not extended). Equity raise approved with 99.92% vote. PSU banks stable with asset quality improving. Target Rs 1,150 (14.6% from entry) and 7% stop at Rs 930.79 intact. Review date July 29.

₹1,052.30

Post-mortem postmortem-REC-20260611-05-SBIN-2026-08-06 completed on 2026-08-14T03:30:00Z.

₹1,076.80

upcoming

Accepted from analysis task analysis-2026-06-03-0830

₹145.00

At Rs 145.61 the stock is just above the Rs 145 entry and above the 200-DMA, but RSI near 80 makes fresh risk unattractive.

₹145.05

Trading at Rs 147.25, up 1.6% from Rs 145 entry. Technicals are strengthening: RSI 59-61 bullish, MACD positive and expanding, price well above 200-DMA (~Rs 119-135). Q4 PAT up 46% YoY with EBITDA up 42% confirms the value_fundamental thesis. June 12 institutional investor meetings and credit rating revision are incremental positives. Review date July 21 still ahead with Rs 160 target in sight.

₹154.46

At ~Rs 150.8 vs entry Rs 145 (+4%) after a -2.4% post-Q1 reaction; Q1 topline surged but profit growth was muted and margins contracted, so the catalyst is weak even though the Rs 160 target and Rs 136 stop are both untested.

₹154.46

Rs 146.5 (+1.0% vs entry Rs 145); RSI ~50 neutral, price above the 200-DMA (Rs 121), June European car registrations +13% YoY support the thesis; Rs 160 target by the July 21 review.

₹154.46

Auto-WATCH: price ₹168.90 reached target ₹160.00 — review for exit

₹168.90

Traded ₹142.7-146.3 around July 10 (-1.6% from ₹145 entry), well above the ₹136.3 stop; Nuvama ₹168 target and 21-analyst coverage with 0 sell ratings keep the thesis intact; ex-dividend ₹0.25 on July 14.

₹167.68

Rs 160 target hit - stock is ~Rs 166 (record high Rs 168.95) after a record Q1, so bank the 10%+ gain per target-hit policy; revised analyst targets (Rs 165-190) suggest upside could continue.

₹167.68

₹142.5 vs entry ₹145 (-1.7%); RSI ~50, MACD positive, price ~15-19% above the 200-DMA (~₹123), and Nuvama raised its target to ₹168 - thesis intact ahead of the Jul 21 review.

₹167.68

Q1 profit +102% (Aug 6) drove a ~7% surge to a 52-week high of Rs 164.60, exceeding the Rs 160 target; +13% vs entry Rs 145 - target hit, move to watch per target_hit_action.

₹167.68

Price ~Rs 150-155 after weekly breakout vs entry Rs 145 (+4-7%); Q1 record revenue +17% and PAT +102% confirm the thesis; Rs 160 target ~3-6% away, hold with support at Rs 142.

₹167.68

MOTHERSON at ~Rs 168 vs Rs 145 entry (+16%) - Q1 PAT doubled to Rs 1,032 cr and the Rs 160 target was breached on Aug 7; per config the target-hit action moves it to WATCH with analysts at Rs 165-178.

₹167.68

At ₹145.91 vs entry ₹145 (flat); thesis intact - Nuvama Buy TP ₹168 (Jul 16), Yutaka Giken deal closed Jul 22, EU car sales +13% in June - and price holds above the 200-DMA and the ₹136.3 stop-loss.

₹167.68

At Rs 167.68 (+15.6% vs entry Rs 145) the Rs 160 target has been exceeded on record Q1 results (PAT +101.6%) - target-hit rule moves the pick to WATCH; analysts have raised targets to Rs 165-190, so a re-entry on a pullback to Rs 160 can be considered.

₹167.68

Post-mortem postmortem-REC-20260603-05-MOTHERSON-2026-07-21 completed on 2026-08-14T03:30:00Z.

₹167.68

upcoming

upcoming

Accepted from analysis task analysis-2026-05-27-0830

₹4,447.00

Price remains above the 200-DMA with RSI near 56 and Q4 revenue/EBITDA growth still supporting the thesis.

₹4,529.10

Auto-WATCH: ex_dividend event on 2026-05-29 is 0 days away

₹4,529.10

At about Rs 4,538, the stock is above entry and above its 200-DMA with bullish MACD, so the Q4 defensive-growth thesis remains intact.

₹4,529.10

At about ₹4,318, the stock is down roughly 2.9 percent from entry but still above its 200-DMA, so keep it on watch because MACD has turned bearish.

₹4,281.50

TORNTPHARM closed at Rs 4,463.70, 0.4% above entry, and all tracked simple moving averages remain bullish despite a bearish short-term MACD.

₹4,455.00

At Rs 4,455 the position is flat and above its Rs 3,955 200-DMA, but bearish MACD weakens the post-results continuation case.

₹4,455.00

At ₹4,572.20 Torrent is 2.8% above entry and above all six tracked moving averages, preserving the defensive-growth thesis.

₹4,588.30

Auto-WATCH: price ₹4947.80 reached target ₹4900.00 — review for exit

₹4,947.80

Trading at Rs 4,467.90, essentially flat from Rs 4,447 entry. Technicals remain decisively bullish: RSI 57-61, MACD strongly positive, price far above 200-DMA (~Rs 2,803-3,978). Q4 revenue up 42% YoY with 41% EBITDA growth confirms the value_fundamental thesis. Cup and handle breakout pattern targets Rs 5,000-5,200. Stock eased for fifth straight session by June 18, but this is normal consolidation within an uptrend. Review date July 14 still ahead.

₹4,995.00

Target price ₹4,900 EXCEEDED — stock hit ₹5,068 on Aug 5 post strong Q1 FY27 results (PAT +3.3%, revenue +55% YoY). JB Pharma integration ahead of schedule with cost synergies exceeding ₹100 Cr. Morgan Stanley upgraded to Overweight (₹5,623). However, Pharma sector faces Trump tariff overhang (100-200% on generics from 2028), semaglutide batch recall is temporary but unresolved, and stock is past review date of July 14. Target-hit action per config: move to WATCH.

₹4,995.00

Up 1.2% from entry at Rs 4,499.30. JB Pharma acquisition (46.39% stake for Rs 11,917 Cr, Rs 25,689 Cr total equity value) announced June 29 is a transformative catalyst — creates a diversified healthcare platform with CDMO and ophthalmology access. Morgan Stanley upgraded to Overweight with Rs 5,623 target. Pharma sector MF flows up 30.6% YoY. Target Rs 4,900 (10%) and 6% stop intact.

₹4,995.00

Target Rs 4,900 hit — closed ~Rs 4,974-5,030 (intraday high Rs 5,068.50 on Aug 5), +13% vs entry Rs 4,447; Q1 revenue +54.9% and PAT +3.3%; Morgan Stanley upgraded to Overweight TP Rs 5,623.

₹4,995.00

~Rs 4,818-4,857, +8-9% from entry at Rs 4,447; NCLT sanctioned the JB merger on Jul 6 and the stock made a 52-week high of Rs 4,878.90, but RSI 74 is overbought and target Rs 4,900 is only ~1-2% away — watch for a target-hit transition.

₹4,995.00

Torrent ~Rs 4,852.6 (Jul 8 snapshot) and above the Rs 4,900 target by mid-July (Rs 4,987 on Jul 16, 52-week high Rs 5,085) — target hit, so per config (target_hit_action) the position moves to WATCH; momentum cooled (RSI 74 overbought on Jul 7, ~47-54 by mid-July).

₹4,995.00

Post-mortem postmortem-REC-20260527-06-TORNTPHARM-2026-07-14 completed on 2026-07-14T08:30:08+05:30.

₹4,869.00

upcoming

Accepted from analysis task analysis-2026-05-22-0830

₹3,931.00

At about Rs 3,933, LT is flat to entry and above the 200-DMA, but bearish MACD keeps it on watch until momentum improves.

₹3,933.00

At about Rs 4,035 versus Rs 3,931 entry, the order-book thesis remains intact and price is still above the 200-DMA zone.

₹4,035.00

Auto-WATCH: agm event on 2026-06-05 is 4 days away

₹4,090.00

At Rs 4,090 versus Rs 3,931 entry, the capex thesis is working and price remains above the 200-DMA.

₹4,090.00

Auto-WATCH: agm event on 2026-06-05 is 3 days away

₹4,012.00

At about ₹4,001, the stock is above entry and above its 200-DMA, while MACD and MA structure still support the capex thesis.

₹4,010.00

Auto-WATCH: agm event on 2026-06-05 is 1 days away

₹3,953.20

At Rs 3,953.20 the stock remains above the Rs 3,931 entry and 200-DMA, but bearish MACD keeps sizing unchanged.

₹3,953.20

Auto-WATCH: agm event on 2026-06-05 is 0 days away

₹3,948.00

At about ₹3,948 versus ₹3,931 entry, the stock is close to entry and technicals remain above the 200-DMA with positive MACD.

₹3,948.00

At ₹3,875.50 the stock is 1.4% below entry and has slipped just below its ₹3,897 200-SMA with bearish MACD despite a strong order book.

₹3,870.50

At ₹3,862 L&T is 1.8% below entry, below its ₹3,906 200-DMA and below every tracked moving average, invalidating the bullish technical gate.

₹3,871.70

Post-mortem postmortem-REC-20260522-05-LT-2026-07-09 completed on 2026-08-14T03:15:00.000Z.

₹3,871.70

upcoming

upcoming

Accepted from analysis task analysis-2026-05-20-0830

₹1,211.00

TATACONSUM closed near Rs 1,208.70 versus Rs 1,211 entry and still holds above its 200-DMA, so the Q4 value-fundamental thesis remains intact.

₹1,210.00

Auto-WATCH: ex_dividend event on 2026-05-25 is 3 days away

₹1,195.20

At Rs 1,144 the stock is only slightly above its 6% stop from Rs 1,211, with RSI below 25 and bearish MACD.

₹1,143.20

Post-mortem postmortem-REC-20260520-02-TATACONSUM-2026-07-07 completed on 2026-08-14T05:00:00Z.

₹1,143.20

upcoming

upcoming

Accepted from analysis task analysis-2026-06-04-0830

₹18,900.00

At about ₹18,634 versus ₹18,900 entry, the Q4 catalyst is intact and price remains above the 200-DMA, but the position needs the tight 6% stop.

₹18,634.00

Auto-WATCH: drawdown -3.3% exceeds tolerance -3% for news_catalyst

₹18,280.00

Auto-EXIT: P&L -6.1% breached stop loss -6%

₹17,750.00

Post-mortem postmortem-REC-20260604-05-PTCIL-2026-06-15 completed on 2026-06-15T09:00:00+05:30.

₹17,750.00

Accepted from analysis task analysis-2026-05-21-0830

₹506.00

At about Rs 503.7 versus Rs 506 entry, price remains above the 200-SMA near Rs 440.8 and the crude-linked thesis is intact.

₹502.10

At about Rs 483 versus Rs 506 entry, the position is near the sector-tailwind drawdown limit and crude has cooled.

₹483.00

At ₹481 the stock is about 4.9% below entry and near the sector-tailwind drawdown limit, while bearish MACD and weak relative strength show crude is not confirming the thesis.

₹480.00

Post-mortem postmortem-REC-20260521-03-OIL-2026-06-11 completed on 2026-06-11T03:34:06Z.

₹480.00

Accepted from analysis task analysis-2026-05-19-0830

₹297.50

ONGC is near Rs 296.5 versus Rs 297.5 entry and remains above its 200-DMA while crude stays firm, so the sector-tailwind thesis is intact.

₹296.45

Auto-WATCH: earnings event on 2026-05-26 is 5 days away

₹298.65

ONGC closed near Rs 298.30 versus Rs 297.50 entry and remains above its 200-DMA while crude and royalty relief support the thesis.

₹298.65

Auto-WATCH: earnings event on 2026-05-26 is 4 days away

₹295.80

The stock closed near Rs 274.05, below the 6% stop from entry and slightly below the cited 200-SMA after Q4.

₹273.30

Post-mortem postmortem-REC-20260519-01-ONGC-2026-06-09 completed on 2026-06-09T08:46:57+05:30.

₹273.30

upcoming

Accepted from analysis task analysis-2026-05-29-0830

₹164.00

At Rs 156.65 versus Rs 164 entry, the earnings trade has broken below the recent 200-SMA area with bearish MACD and a near 5% drawdown.

₹156.65

Post-mortem postmortem-REC-20260529-06-ASHOKLEY-2026-06-02 completed on 2026-06-02T08:47:54+05:30.

₹156.65

upcoming

Accepted from analysis task analysis-2026-05-15-1120

₹403.35

Price is near entry and above the 200-DMA, but metals lost relative strength on 15 May and MACD evidence is bearish.

₹402.55

At about ₹400.45, NALCO is below the reported MA200 sell zone near ₹409-₹418, so the original above-200-DMA thesis condition has failed.

₹400.35

Post-mortem postmortem-REC-20260515-01-NATIONALUM-2026-06-01 completed on 2026-06-01T03:19:15.952Z.

₹400.35

Accepted from analysis task analysis-2026-05-22-0830

₹10,650.00

At about Rs 10,566, Bajaj Auto is slightly below entry but still above the 200-DMA with the Rs 12,000 buyback catalyst intact.

₹10,566.00

Auto-WATCH: ex_dividend event on 2026-05-29 is 3 days away

₹10,504.00

Post-mortem postmortem-REC-20260522-04-BAJAJ-AUTO-2026-05-29 completed on 2026-05-29T03:16:46Z.

₹10,801.00

upcoming

upcoming

Accepted from analysis task analysis-2026-04-23-0830

₹7,966.00

The stock remains above key long-term averages and the electrification thesis is intact. Momentum is constructive without appearing excessively stretched.

₹8,062.50

At about Rs 9,003, the stock is up roughly 13% from entry after strong Q4 results, but RSI is above 70 and stochastic is near 96.

₹8,175.50

At Rs 9,003 on May 7, Polycab is about 13% above entry after strong Q4 results, so hold but do not add into RSI above 70.

₹8,175.50

Current price around Rs 9,003 is about 13% above the Rs 7,966 entry, while RSI near 75 and stochastic near 96 show overbought risk after the Q4 result spike.

₹8,175.50

Post-mortem postmortem-REC-20260423-07-POLYCAB-2026-05-14 completed on 2026-05-14T03:17:18Z.

₹8,175.50

Accepted from analysis task analysis-2026-04-30-0830

₹1,556.90

GESHIP closed near Rs 1,576.8 on April 30, modestly above the Rs 1,556.9 entry, and the shipping value thesis is still alive. Move to WATCH because RSI and stochastic are now above preferred limits after the fast move, so the trade needs a tight trailing stop rather than fresh averaging.

₹1,556.90

At about Rs 1,552, the stock is flat versus the Rs 1,556.90 entry and remains above the 200-DMA while the Q4 event is still ahead.

₹1,556.90

At Rs 1,552.40 on May 7, GESHIP is near the Rs 1,556.90 entry and still above the 200-DMA, but the tactical trade has not extended yet.

₹1,556.90

At Rs 1,552.40, the stock is nearly flat versus the Rs 1,556.90 entry and remains above the 200-DMA with bullish MACD, so the tactical thesis is still alive.

₹1,556.90

GESHIP remains above its 200-SMA with RSI 64.90, but stochastic at 78.96 and the expired tactical hold window argue for tighter monitoring.

₹1,556.90

Post-mortem postmortem-REC-20260430-06-GESHIP-2026-05-11 completed on 2026-05-11T08:48:50+05:30.

₹1,556.90

Accepted from analysis task analysis-2026-04-17-0830

₹4,122.20

Thesis intact with record order book and Q4 pipeline confirmed. Price at Rs 4,105 marginally below Rs 4,122 entry; within drawdown tolerance for sector_tailwind (-5%). Review date May 8 stands.

₹4,068.60

L&T traded near Rs 4,023-Rs 4,029 versus the Rs 4,122.2 entry, and Q4 commentary introduced near-term execution and Middle East pressure concerns. The order-book thesis remains credible, but the post-result momentum profile has weakened, so keep it on WATCH until price stabilizes.

₹4,104.00

Post-mortem postmortem-REC-20260417-06-LT-2026-05-08 completed on 2026-05-08T03:22:57Z.

₹4,104.00

Accepted from analysis task analysis-2026-04-17-0830

₹3,227.90

Thesis reinforced by FY26 tractor/SUV volume records and April price hikes. Current Rs 3,202 vs Rs 3,227 entry (-0.8%), well within tolerance. Hold into May 8 review.

₹3,217.90

M&M closed near Rs 3,247.05, modestly above the Rs 3,227.90 entry, and the SUV/tractor volume thesis remains sound. However, Dhan and Trendlyne snapshots show mixed long moving-average structure with price below the 200-DMA in their Indian technical data, so the position should stay on watch rather than be upgraded.

₹3,247.50

M&M is less than 1% below entry and the auto thesis remains supported by record FY26 SUV volumes and all-time high tractor sales. Technicals are acceptable with RSI near 55 and price above the relevant 200-DMA snapshot, though short-term auto sentiment can react to EV competition narratives.

₹3,202.20

M&M is down about 5.6% from entry, breaching the sector-tailwind tolerance. It is also below the 200-DMA, so the bullish technical gate has failed.

₹3,035.30

Post-mortem postmortem-REC-20260417-05-M&M-2026-05-08 completed on 2026-05-08T03:30:02Z.

₹3,035.30

Accepted from analysis task analysis-2026-04-17-0830

₹456.95

+1.1% from Rs 456.95 entry on continued defence order flow. March Rs 6,795 cr wins plus export growth validate thesis; Q4 print late May is the next catalyst.

₹461.90

The defence thesis remains valid, but recent price weakness has reduced technical confidence. Move to watch until momentum and breadth improve.

₹436.30

BEL closed near Rs 431.3, about 5.6% below the Rs 456.95 entry, breaching the sector-tailwind drawdown tolerance. The stock is still above the 200-DMA, but MACD is bearish and the moving-average sell count now exceeds the buy count, so the short-term thesis has failed.

₹437.10

Post-mortem postmortem-REC-20260417-04-BEL-2026-05-08 completed on 2026-05-08T03:15:19Z.

₹437.10

Accepted from analysis task analysis-2026-04-20-0830

₹1,107.90

Thesis intact: ICICI's beat sets a strong bar, Q4 print scheduled for May 15 and ex-dividend May 18. Current ₹1,104 vs entry ₹1,107.9 is a 0.35% drawdown — well inside earnings-play tolerance. Banking sector rotation supportive.

₹1,111.85

SBI remains close to entry, but banking has been less convincing than the headline index and provisioning concerns remain a sector overhang. Keep on WATCH until earnings timing and credit-cost commentary become clearer.

₹1,088.15

Post-mortem postmortem-REC-20260420-07-SBIN-2026-05-04 completed on 2026-05-07T16:09:20Z.

₹1,071.95

upcoming

upcoming

Accepted from analysis task analysis-2026-04-23-0830

₹2,793.00

The core commodity-volatility thesis remains valid, but RSI is close to overbought territory. Holding is acceptable, but adding here should wait for a cooler entry.

₹2,826.10

The pullback cooled the most stretched part of the move while the exchange-volume thesis remains intact. Hold, but keep position sizing disciplined because RSI remains high.

₹2,826.10

MCX closed near Rs 2,971.5, materially above the Rs 2,793 entry, and commodity volatility still supports exchange volumes. Move to WATCH because RSI near 79 and stochastic near 96 show a stretched short-cycle setup ahead of the May 3 review window.

₹2,912.00

At Rs 3,042.60 on May 7, MCX is about 8.9% above entry and the volatility-volume thesis remains intact, but stochastic is high.

₹2,912.00

At Rs 3,042.60, MCX is about 8.9% above entry, but RSI 71.1 and retail concern about exchange glitches justify moving to watch.

₹2,912.00

Post-mortem postmortem-REC-20260423-06-MCX-2026-05-04 completed on 2026-05-07T16:02:25Z.

₹2,912.00

Accepted from analysis task analysis-2026-04-22-1348

₹651.80

The stock is down about 4.0% from entry but still above its 200-DMA and within the sector-tailwind drawdown tolerance. Keep the trade technically gated.

₹627.45

Auto-WATCH: drawdown -7.3% exceeds tolerance -5% for sector_tailwind

₹604.00

Sun TV is down materially from the Rs 651.8 entry and the short media-rotation thesis has failed. With the price now around Rs 595.5 and below the intended tactical support zone, capital should be redeployed rather than extending a losing exploratory trade.

₹595.50

Post-mortem postmortem-REC-20260422-05-SUNTV-2026-05-04 completed on 2026-05-07T15:54:34Z.

₹595.50

Accepted from analysis task analysis-2026-04-20-0830

₹219.42

Down 0.4% since entry but mid-cap bid continues; order-book narrative intact (RDSO ₹105.7 cr, Mysuru-Hassan ₹729 cr revision). Review date April 30 gives 9 sessions to play out into Q4 announcement window (late May). Stop held at -3% (news_catalyst drawdown tolerance).

₹221.67

RITES closed near Rs 220.19 versus the Rs 219.42 entry, so the trade is only marginally positive. The order-book catalyst remains valid, but Dhan technicals show price below the 200-DMA and stochastic overbought, so this should be monitored rather than treated as a clean hold.

₹221.67

RITES is slightly above the Rs 219.42 entry, but the latest Dhan technical snapshot showed price below the 200-DMA while stochastic was overbought. Since this is a bullish news-catalyst thesis and the configured technical gate rejects below-200DMA setups, exit rather than extend the short-hold trade.

₹221.43

Post-mortem postmortem-REC-20260420-07-RITES-2026-04-30 completed on 2026-04-30T03:47:05Z.

₹221.43

Accepted from analysis task analysis-2026-04-22-1348

₹1,052.15

The April 24 results and final-dividend catalyst is confirmed, but price is now down about 4.1% from entry. Move to WATCH rather than EXIT because the earnings event is imminent.

₹1,011.95

The earnings-play thesis failed after the post-result drawdown exceeded the acceptable threshold. Capital should be redeployed rather than waiting for a delayed recovery.

₹974.00

Post-mortem postmortem-REC-20260422-06-SHRIRAMFIN-2026-04-29 completed on 2026-04-30T03:47:05Z.

₹974.00

upcoming

Accepted from analysis task analysis-2026-04-05-0601

₹159.75

Near entry at ₹160; MSEDCL contract adds long-term visibility; coal-based insulated from crude

₹159.75

Up 21.5% from entry (₹194.15 vs ₹159.75) and trading near the 52-week high of ₹193.37. JM Financial estimates Q4 PAT may decline 12.3% YoY even as the stock prices in summer demand tailwinds (mid-May to September). Move to WATCH to lock in gains mentally, tighten stop, and reassess post-Q4 prints.

₹194.15

RSI 86.2 strongly overbought with 6-session record high streak; +24% from Rs 159.75 entry has blown through any reasonable sector_tailwind target. Stochastic 92. Thesis has played out — book the gain rather than hold through inevitable mean-reversion. Prior WATCH was too lenient.

₹204.19

Post-mortem postmortem-REC-20260405-02-ADANIPOWER-2026-04-29 completed on 2026-04-30T03:47:05Z.

₹204.19

Accepted from analysis task analysis-2026-04-05-0601

₹1,395.00

Above entry at ₹1,402; IT defensive rally intact; Q4 results April 21

₹1,395.00

At about Rs 1428.5 versus the Rs 1395 entry, the trade is still positive, but the IT-recovery thesis has weakened after TCS’s mixed read-through. Move it to WATCH until Nifty IT can reclaim leadership and prove it can hold above the 31,000 resistance zone.

₹1,428.50

Q4 FY26 on April 21 with interim dividend under consideration. Stock up ~4% from entry with IT sector recovery intact post-TCS, and FY27 guidance of 4-6% would be a positive catalyst. Maintain HOLD through the event; re-evaluate post-results based on FY27 commentary.

₹1,450.20

Q4 print today: PAT ₹4,488 cr (+4.2%) — slightly below ₹4,716 cr consensus. Current ₹1,424 vs entry ₹1,395 = +2.1%, in hit zone. FY27 guidance is the swing factor; if guide is cautious, stock gives back gains. Move to WATCH and reassess on April 22 open once guide is digested. Review date April 26.

₹1,439.90

HCLTech is about 7.4% below the Rs 1,395 entry using the embedded latest price and was down over 9-10% intraday after Q4 results. The FY27 guide weakened the sector-tailwind thesis, and the current price is below the prior 200-DMA zone, so the configured drawdown and technical gates both argue for exit.

₹1,291.50

Post-mortem postmortem-REC-20260405-01-HCLTECH-2026-04-29 completed on 2026-04-30T03:47:05Z.

₹1,291.50

Accepted from analysis task analysis-2026-04-16-1724

₹1,345.50

Q4 FY26 results are on April 18 (corrected from the thesis note of April 26) — just one trading day away. Stock is essentially flat at ₹1,343.90 vs entry of ₹1,345.50 with all the upside still ahead. Brokerage targets of ₹1,420-1,500 (5-11% upside) and analyst PAT consensus of ₹11,500-12,200 cr support holding through the event.

₹1,343.90

ICICI Bank closed near Rs 1,388.65, up about 3.2% from the Rs 1,345.50 entry, and the Q4 earnings catalyst has already occurred with profit growth and asset-quality improvement. Because this was an earnings-play thesis, the event is now largely monetized; exit locks the gain rather than converting it into an unplanned long hold.

₹1,389.20

Post-mortem postmortem-REC-20260416-03-ICICIBANK-2026-04-23 completed on 2026-04-23T10:57:10Z.

₹1,389.20

upcoming

Accepted from analysis task analysis-2026-04-08-0900

₹2,568.10

TCS closed at Rs 2,555 on April 8 — marginally below the entry price of Rs 2,568.10. The core earnings_play thesis remains intact and has not yet played out: Q4 FY26 results are due today after market hours. Analyst consensus is strongly positive (revenue +9% YoY, PAT +14-15% YoY, EBIT margin recovery above 25%). The catalyst is hours away — exiting before the event would negate the thesis entirely. Hold through the results announcement.

₹2,561.10

TCS is trading at Rs 2,547, below the entry price of Rs 2,568 (down ~0.8%). The Q4 results on April 9 beat estimates with 12% YoY profit growth and $12B TCV, but the stock reacted muted. The earnings_play thesis has now been realized — results are out and the catalyst has passed. Per the thesis default hold of 2 days for earnings_play (entered April 8, now April 10), the position is at its hold limit. Move to WATCH as the near-term catalyst has played out without meaningful upside capture, though analyst targets remain bullish at up to Rs 3,350.

₹2,518.20

The earnings_play catalyst has fully played out. Despite strong Q4 numbers, the stock fell on the first-ever annual USD revenue decline. With the hold period expired, geopolitical risks resurfacing (Iran talks failed April 12), and the stock down ~3.5% from entry at ~2477, the thesis is exhausted. Exit to limit further losses.

₹2,480.30

Post-mortem postmortem-REC-20260408-03-TCS-2026-04-16 completed on 2026-04-16T17:55:00+05:30.

₹2,478.40